An Exciting New Partnership

Avicenna proudly announces an exclusive partnership with Genemind Bioscience Co. Ltd. , Specializing in the independent R&D and manufacturing of molecular diagnosis technology platform centered on DNA sequencing system, GeneMind Biosciences is devoted to constructing a precision medicine ecosystem to serve human life and health through collaboration with genetic testing service providers and medical institutions.

And offers the “equipment-reagent-flow cell-software” total platform solution as the following:

1- Equipment


-Genolab M with output up to 150GB

– FASTASeq 300 with output up to 75GB

-SURFSeq 5000 with output up to 600 GB

And Genemind offers 2 types of Flow cell, Flow Cell -Medium (FCM) and Flow cell-High (FCH):

Sequencer Name   FCM (Data output/FC)  FCH (Data output/FC)

Genolab M              18GB-75 GB                      37GB- 150GB

FASTASeq 300       5GB-30 GB                       12.5GB- 75GB

SURFSeq 5000       50 GB-150 GB               100 GB-600 GB

B- Automated Sample Preparation System

-MrLH-96 Dx (96 sample/run)

2- Reagents

A-Library Preparation

B-Flow Cell

3- Software

The main applications offered by Genemind include:

-NIGM is a form of non-invasive prenatal testing (NIPT)

-Preimplantation Genetic Testing for Aneuploidy (PGT-A)

-Clinical diagnostic whole‐exome sequencing (WES)

This collaboration aims to make cutting-edge NGS products more accessible across the Gulf region, South Africa, Levant, North, West, and East Africa.

This partnership allows for the utilization of cutting-edge technology in genomic research and analysis.


Avicenna has announced the launch of its new product Aviseq.
AviSeq is a range to analyse genetic markers of oncology, inherited diseases, infectious diseases, and inflammation as well as Whole Exome Sequencing with Avicenna’s range of CE-IVD and RUO Next Gen Library Prep kits on multiple platforms.
AviSeq will meet the needs of a wide range of customers in the Genomics and Diagnostics fields and provide added value to the labs without the high additional cost.


  1. Stable ready-to-use reagents allow ease of use
  2. A wide range of human disease targets
  3. Highly accurate & specific detection of germline and somatic mutations
  4. Multiple NGS platforms
  5. Minimum DNA sample volume required
  6. Sequence-ready libraries in ~ 6hrs

The main applications offered by Aviseq include:

For more information:

Avicenna at STBC, Tunisia : Sociètè Tunisienne de Biologie Clinique

Our local distributor Sogemed participated in the well-known STBC 2023 Event in Tunisia where they proudly displayed our Avichem Midi and Mini.

4 Installations of the Avichem Mini in Morroco

Avicenna is proud to announce the installation of 4 Avichem Mini systems in multiple customer sites in Morocco with our local distributor, Somapred.

Avicenna ™ at MEDLAB Middle East 2023, Dubai, UAE

AVICENNA ™ participated at MEDLAB Middle East 2023 on 6-9 February at Dubai World Trade Centre in Dubai.

We would like to thank our customers and are grateful for their support and taking the time to visit us.

Please check out the photos below:

Avicenna™ has successfully and officially obtained the IVDR Certificate

We are pleased to announce that Avicenna™ has successfully and officially obtained the IVDR Certificate, according to Regulation (EU) 2017/746, issued by the Belgian Authority and had no remarks for the following products:

Avichem Mini
Avichem Midi

Our esteemed distributor “Sogemed” participated 35th edition of JNBC

We are pleased that our esteemed distributor “Sogemed” participated and showcased our products in the 35th edition of JNBC (Journees Nationales de Biologie Clinique) from 26th- 28th of May 2022 in Hammamet City- Tunisia.


The first regional technical training

Avicenna™  is pleased to give the first Regional Technical training on based in Dubai-UAE Avichem range (systems and reagents), since it was attended by application and engineering teams of Avicenna distributors in Pakistan, Kenya, Nigeria, Egypt, Tunisia and Mauritius.

The training was given by Avicenna technical team.


Avicenna launches its new compact size clinical chemistry analyzer

Avicenna has announced the launch of its new compact size clinical chemistry analyzer, AviChem MiniTM, a small size analyzer with high potential for routine and special tests.

AviChem MiniTM is one of the smallest benchtop automation analyzers. Its unique simple lightweight and compact design with an optional battery allows easy transfer and more flexibility, making it a perfect solution for remote areas. The AviChem MiniTM system has high performance with a throughput of 150 tests per hour and random access of samples at any time.

Avicenna’s Product Manager, Nisreen Haddadin, emphasized, “In our vision as a company, we always look for the addition of innovative products to our portfolio that are simple and easy-to-use but robust and highly efficient at same time. I believe that the launch of the AviChem MiniTM analyzer will meet the needs of a wide range of customers in the clinical chemistry field and provide added value to small labs who plan to move from semi-automation to full automation without the high additional cost.”

Please read the Press Release

Avicenna ™ at MEDLAB Middle East 2020, Dubai, UAE

AVICENNA ™ participated in MEDLAB Middle East 2020 on 3-6 February at Dubai World Trade Center in Dubai.

Thank you all for visiting Avicenna ™ at MEDLAB Middle East 2020.

We appreciate your visit and interest in our booth, our new products, and our solutions.

It was really nice to see you and discuss business opportunities at the show.

Please check out the photos below.